Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430345 · ClinicalTrials.gov registry record · Phase 1
Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department
A Phase 1 study, sponsored by The Cooper Health System.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT07430345 is a Phase 1 study that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 48 participants.
The verdict
NCT07430345, a Phase 1 study, is actively recruiting participants, sponsored by The Cooper Health System.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if buprenorphine can treat pain in older adults who have broken bones. The main questions it aims to answer are: Is buprenorphine as effective as opioids to treat pain? Are there less side effects with buprenorphine? Researchers will compare buprenorphine and hydromorphone to see if there are differences in pain control and side effects. Participants will be given one of the two study drugs after breaking a bone and asked about their pain scores and side effects for the next 48 hours.
Interventions
- DRUG Buprenorphine 0.15 MG
- DRUG Hydromorphone 0.25 mg IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-05-07 |
| Est. Completion | 2027-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07430345
The ClinicalTrials.gov registry entry for NCT07430345 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine 0.15 MG is the first listed.
NCT07430345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07430345 about?
NCT07430345 is a clinical study titled "Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department". The goal of this clinical trial is to learn if buprenorphine can treat pain in older adults who have broken bones. The main questions it aims to answer are: Is buprenorphine as effective as opioids to treat pain? Are there less side effects with buprenorphine? Researchers will compare buprenorphine...
What is the current status of trial NCT07430345?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2026-05-07. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07430345?
The interventions under investigation include: Buprenorphine 0.15 MG (DRUG), Hydromorphone 0.25 mg IV (DRUG).
Who is sponsoring clinical trial NCT07430345?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.